Blog
16 November 2020
Using CANTAB to examine the potential synergistic effects of a combination of omega-3 fatty acids, carotenoids and vitamin E on the cognitive health and function of patients with MCI.
Dr Rebecca Power, Postdoctoral Researcher at the Nutrition Research Centre Ireland, shared the role that CANTAB played in her latest publication: Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1
Read on
5 November 2020
Digital Health Event 2020 | Key takeaways from the industry experts
Industry experts working at the forefront of drug development, devices and digital health shared their lessons learned delivering virtual trials during the Covid-19 pandemic at Cambridge Cognition’s fourth annual Digital Health Event. Catch up on the key takeways from this thought-leading discussion.
Read on
4 November 2020
Automated administration of Serial Subtraction in a remote data collection context: novel timing features related to task difficulty and participant demographics
New research presented at CTAD 2020 reports the successful derivation of novel measures of timing for a more nuanced assessment of performance on the Serial Subtraction task.
Read on
20 October 2020
Unlocking cognitive research during lockdown: post-webinar Q and A
The volume of discussion and questions during our recent webinar: Remote Cognitive Testing and Lessons Learned During Lockdown was great to see. Unfortunately we were unable to answer all the questions in the time we had so Dr Caroline Skirrow has put together a Q and A addressing some of the key themes raised.
Read on
13 October 2020
CANTAB Research Grant assists research into defining cognitive phenotypes in individuals with CNVs associated with neurodevelopmental and neuropsychiatric disorders
Ciara Molloy recently spoke to us about the impact that receiving one of the three 2020 CANTAB Research Grant prizes will have on her research: ‘The impact of rare copy number variants on cognition: Defining cognitive phenotypes in individuals with CNVs associated with neurodevelopmental and neuropsychiatric disorders.’
Read on
5 October 2020
2020 CANTAB Research Grant supports research into combined dexmedetomidine / ketamine nasal spray for analgesia
The winner of one of the three 2020 CANTAB Research Grant prizes, Dr Amie Hayley, Swinburne University of Technology explains the impact CANTAB will have on her research: Combined dexmedetomidine/ketamine nasal spray for analgesia: a pilot feasibility and efficacy trial.
Read on
23 September 2020
CANTAB Research Grant funds new ways to assess vascular cognitive impairment and dementia (VCID) in chronic lung disease
Dr Simone De Luca recently received the 2020 CANTAB Research Grant primary award for her project: “New ways to assess vascular cognitive impairment and dementia (VCID) in chronic lung disease”. We spoke to her about the impact winning would have on her research.
